AMC
Asset Management Corp’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $343K | Sell |
7,580
-2,875
| -27% | -$130K | 0.27% | 80 |
|
|
2022
Q4 | $425K | Sell |
10,455
-1,175
| -10% | -$47.8K | 0.36% | 78 |
|
|
2022
Q3 | $760K | Hold |
11,630
| – | – | 0.46% | 38 |
|
|
2022
Q2 | $707K | Sell |
11,630
-800
| -6% | -$48.6K | 0.46% | 46 |
|
|
2022
Q1 | $780K | Buy |
12,430
+1,365
| +12% | +$85.7K | 0.39% | 53 |
|
|
2021
Q4 | $839K | Buy |
11,065
+288
| +3% | +$21.8K | 0.42% | 54 |
|
|
2021
Q3 | $1.21M | Buy |
10,777
+1,127
| +12% | +$126K | 0.6% | 36 |
|
|
2021
Q2 | $1.56M | Sell |
9,650
-1,270
| -12% | -$206K | 0.9% | 24 |
|
|
2021
Q1 | $1.33K | Buy |
10,920
+7,970
| +270% | +$971 | 0.57% | 30 |
|
|
2020
Q4 | $590K | Hold |
2,950
| – | – | 0.33% | 66 |
|
|
2020
Q3 | $247K | Buy |
+2,950
| New | +$247K | 0.15% | 114 |
|